BNTC
Benitec Biopharma·NASDAQ
--
--(--)
--
--(--)
5.79 / 10
Netural
Fund flow scores 7.56 (good), with medium and large investors net inflowing, though overall trend is negative. Analyst coverage is limited to one Strong Buy, with a weighted rating of 4.02 and a 25% historical win rate. Mixed sentiment.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-09
InstitutionHC Wainwright & Co.
Times predicted4
Historical Win Rate25.0%
What is the analyst consensus for BNTC?
- BNTC holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.79/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
